Feb 5, 2021 | Article, News, Press Release
Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of $153 million. Friday’s Wall Street debut was a show of confidence, upsized from an original plan to offer...
Feb 5, 2021 | Article, News, Press Release
Feb. 5, 2021 04:27 UTC EMERYVILLE, Calif.–(BUSINESS WIRE)– Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today...
Feb 1, 2021 | News, Press Release
SAN MATEO, Calif., Feb. 1, 2021 /PRNewswire/ — Phoenix Venture Partners LLC (PVP) announced today that it officially closed its latest flagship venture capital fund, PVP III LP at EOY 2020. The Fund was oversubscribed and its limited partners (both returning and...
Jan 20, 2021 | News, Press Release
While pest insects can have a devastating effect on crops, pesticides can likewise cause a great deal of damage to the environment. That’s where CropCoat comes in, as it’s designed not to kill harmful insects, but to “hide” plants from them...
Jan 12, 2021 | News, Press Release
Vancouver, Wash., January 12, 2021 – AbSci, a leading synthetic biology company enabling drug discovery and biomanufacturing of next-generation biotherapeutics, today announced the acquisition of Denovium, Inc., an artificial intelligence (AI) deep learning company....
Dec 16, 2020 | News, Press Release
BOSTON, Dec. 16, 2020 /PRNewswire/ — NBD Nanotechnologies, the surface coating experts, introduced a significant enhancement to their InvisiPrint product by infusing it with MBED; NBD Nano’s proprietary antimicrobial material. MBED antimicrobial is able...
